Goodwin Procter advised Prime Medicine and Wilson Sonsini Goodrich & Rosati advised Prime Medicine on IP matters related to the transaction, while Davis Polk & Wardwell...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini and Honigman advised Prime Medicine on the deal, while Davis Polk advised the joint book-running managers. Prime Medicine, Inc., a biotechnology company committed to...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Prime Medicine™ on the deal. Prime Medicine™ announced its launch and funding rounds totaling $315 million. Prime Medicine is a biotechnology company founded to...
You must be a Standard 1 Year member to access this content.
